THE ROLE OF ANTIGENS AND HLA CLASS I HAPLOTYPES IN
|
|
- Charlene Stewart
- 5 years ago
- Views:
Transcription
1 Open Access Research Journal Medical and Health Science Journal, MHSJ ISSN: (Print) (Online) Volume 7, 2011, pp THE ROLE OF ANTIGENS AND HLA CLASS I HAPLOTYPES IN INDIGENOUS WOMEN IN TASHKENT WITH HYSTEROMYOMA Immunogenetic analysis on HLA I class in 177 indigenous women with uterine myoma showed the positive association in the risk of uterine fibroids with antigens HLA-B8/B22 and haplotype A28/B22; antigens HLA-A28, Cw5 and haplotype B17-Sw5 played role of auxiliary markers. HLA-antigens A2, B35, Cw4 and haplotypes A2-B35, B5-Cw4 showed the negative association. Carrying immunogenetic studies may be useful to search for individual genes involved in the determination of the disease - uterine fibroids, especially among patients with hereditary anamnesis. LANDISH ISANBAEVA Department of Obstetrics- Gynecology and Perinatal Medicine, Tashkent Institute of Postgraduate Medical Education, Uzbekistan Keywords: Hysteromyoma, tumors, HLA-system antigens and haplotypes. UDC: : :575 Introduction In recent years there has been a definite upward trend in incidence of hysteromyoma. The prevalence of uterine fibroids varies widely, according to foreign authors the average prevalence is about 30% (Volkov et al., 2004; Kazubskaya et al., 2007). According to modern ideas, fibroids are benign tumors of monoclonal origin. The tumor grows as a genetically abnormal clone of cells; due to mutation gains it acquires the ability of unregulated growth. Factors triggering this mechanism are not well established (Egorova et al., 2007; Kazubskaya et al., 2007; Lanchinsky et al., 2004). From a clinical point of view, many researchers identify a number of risk factors that contribute to the emergence hysteromyoma: profuse menstruation, late menarche, frequent abortions, inflammatory diseases of the uterus and appendages, the presence of TORCH infections dishormonal breast diseases and disorders of thyroid function. It is noted also the role of hereditary factors to the disease. The hereditary predisposition is multifactorial in the nature. Thus, the risk of developing fibroids is 4 times higher in women with a burdened heredity of this pathology. When the disease is at a young age the hereditary is much higher. 17.5% cases of oncological diseases in genital sphere and other organs (endometrial, cervical, ovarian, breast, etc.) occur in this category of women (Egorova et al., 2007; Kazubskaya et al., 2007; Lanchinsky et al., 2004). The antigens of HLA histocompatibility system play a significant role in predisposition to tumors. These protein products provide regulation of immune responses, they participate in recognition of their own and foreign agents, and ensure the survival of the human species in terms of endogenous and exogenous aggression (Khaitov and Alekseev, 2001; Karell et al., 2000). There are studies of tumors in various diseases in indigenous Uzbeks (retinoblastoma, colorectal cancer, cancer of the gastrointestinal tract, skin cancer) (Ravshanov et al., 2000; Tuhfatullina et al., 2000; Kuryazov, 2007; Kholikov et al., 2009). However, we have not seen study on the HLA-system in uterine cancer; this state motivated the purpose of this study. Materials and methods We surveyed 177 women aged 20 to 55 years, with a clear diagnosis - uterine fibroids. All clinical examination was conducted at the Department of obstetrics, gynecology and perinatal medicine, Tashkent Institute of Postgraduate Medical Education. The surveyed women were persons of Uzbek nationality, which was determined using the passport data,
2 given the lineage of three generations according to the materials of HLA VII Workshop. Immunogenetic studies (typing HLA class I to identify antigens A, B, CW) were performed at the Institute of Immunology, Academy of Sciences of Uzbekistan. To perform serological typing of HLA-antigens of class I there was used of purified lymphocyte suspension allocated by the method of Boyum (1968). HLA-phenotype was defined using the standard micro-lymphocytes-toxic test of P. Terasaki (Mattius et al., 1970) using a panel of HLA-antisera of the St. Petersburg Institute of Hematology and Blood Transfusion (Gisans company). The control group consisted of 301 donors without autoimmune diseases and heredity; these donors were examined at the Institute of Immunology, Academy of Sciences of Uzbekistan. Healthy patients were belonged to the Uzbek ethnic group of persons living in the region for three generations. Processing of statistical data was performed using programs MS Excel and a number of formulas (Bland et. al., 1996; Müller, Ehninger, and Goldmann, 2003; Howell et al., 1987). Results and discussion The study of the general group of women with hysteromyoma found 35 HLA-class I antigens: 13 antigens for HLA-A locus; 17 antigens for HLA-B locus and 5 antigens at HLA-Cw locus. TABLE 1. COMPARATIVE POLYMORPHISM OF HLA CLASS I ANTIGENS IN THE TOTAL HYSTEROMYOMA GROUP OF PATIENTS N HLA AG% Hysteromyoma (n=177) AG% Healthy curves (n=301) Relative risk (PR) N HLA AG% Hysteromyoma (n=177) AG% Healthy curves (n=301) Relative risk (PR) 1. А В А2 20.9** В А В А В А В *** А В А В ** А В А В А В А Cw А * Cw А Cw В Cw4 15.8*** В Cw5 9.6* В8 14.6*** Cw В Cw В В В Note: N - number of persons with antigen identified; AG - antigen frequency in %; GF - gene frequency; RR - criterion of the relative risk * - P <0.05, *** - P <0.001, ** - P <0.01. Immunogenetic studies in the total group of patients with hysteromyoma in a comparative perspective with a healthy group of Uzbek nationality revealed the characteristic features (Table 1). HLA-A28 antigen was the most frequently registered in HLA-A locus (in 20.3% vs. 4.9% in control, P <0.05). With a lowest frequency was expressed HLA-A2 antigen (in 20.9% vs. 36.9% in the control, P <0.01)
3 It must be noted that antigens were detected in the total group with hysteromyoma: A25-5.6%, A29-4.5%, A24-2.8%, A21-2.2%, A23-1.6% of cases; these antigens were not found in the control group. The study of HLA-B locus in patients with hysteromyoma has found that HLA-B8 and B22 antigens occurred most often (P <0.001) compared with the control (14.6% versus 4.7% in controls; 12.4 % vs. 1.3%). HLA-B35 antigen occurred with the lowest frequency (14.1% versus 27.2% in control, P <0.01). Analysis of data on the distribution of HLA-Cw locus antigens in the general group with hysteromyoma showed that HLA-Cw5 antigen encountered most frequently relatively to control group (9.6% vs. 2.3% in controls, P <0.05). HLA-Cw4 antigen had relatively low frequency comparing to the control (15.8% vs. 36.2%, P <0.001). We have measured the validity of connection with the group of patients with hysteromyoma for the following antigens: B22 (χ²=26.7; etiologic fraction EF=0.112; relative risk RR=10.5; Pc<0.001); B8 (χ²=17.9; EF=0.108; RR=3.8; Pc<0.001). This result points on a positive association of these markers with the risk of developing diseases of hysteromyoma. A28 antigens provided additive effect (χ²=13.5; EF=0.806; RR=4.8), Cw5 (χ²=12.3; EF=0.074; RR=4.4). Negative association to the risk of hysteromyoma was demonstrated by Cw4 (χ²=19.7; PF=1.7; RR=0.3; Pc<0.001), A2 (χ²=12.6; PF=1.3; RR=0.4, Pc<0.01) and B35 (χ²=12.6; PF=1.2; RR=0.4; Pc<0.01). This confirms the protective effect of these antigens. Since the inheritance of HLA-genes occurs in a codominant pattern, we can not rely on a one marker antigen. We took into account the combination of antigens identified in the HLA-phenotype. Analysis of the distribution in frequency of haplotype associations for subtypes HLA AB- Cw and B in the total group with hysteromyoma showed specific characteristics. With the highest incidence in the total group with hysteromyoma occurred the following graphotype variations: A28-B22 (5.6%), A1-B5 (5%), A3-B5 (4.5%), A1-B13, A2-B7 and A10-B8 (3.9% respectively), A1-B7, A3, B8 and A9-B17 (3.3% respectively). With the lowest frequency (1.1%) occurred 30 haplotypes. TABLE 2. SIGNIFICANT HAPLOTYPE ASSOCIATION IN THE TOTAL HYSTEROMYOMA GROUP Haplotypes subtype А-В D H Difference χ² LD RR Р А2-В <0.05 А2-В <0.001 А3-В <0.05 А10-В <0.05 А28-В <0.05 А28-В <0.001 Note: D - expected frequency; H - observed frequency; LD - delta value of linkage disequilibrium; RRcriterion of the relative risk (relative risk); χ ² - Pearson's chi-square test. To study predisposition to predisposition to uterine fibroid disease we analyzed significant haplotype combinations through defining haplotypes frequency (H) and the linkage disequilibrium ratio D. The difference between the observed and expected frequency of their co-occurrence gives a quantitative characterization of gamete association known as the index or the value of linkage disequilibrium. In this subgroup there were found six haplotypes with statistical significance in comparison to the control group. These haplotypes are presented in Table 2. There significant difference in comparison to the control values was set for the following haplotypes: А28-В22 (χ²=12.8; RR=18.0; LD=0.0033; Р<0.001); А28-В18 (χ²=9.08; RR= 8.7; LD=0.0025; Р<0.05); А10-В8 (χ²=6.53; RR=6.1; LD=0.0049; Р<0.05); А3-В8-41 -
4 (χ²=5.13; RR=5.2; LD=0.0040; Р<0.05); А2-В35 (χ²=3.82; RR=0.1; LD=0.0089; Р<0.001); А2-В5 (χ²=2.10; RR= 0.1; LD=0.0072; Р<0.05). Positive nonzero value of the delta linkage disequilibrium was established for all haplotypes; the observed haplotype frequency was 1.3 and 2.2 times higher than a theoretically expected values. However, the true positive association was established for the A28-B22 haplotype and negative one - for the A2-B35 haplotype. There were identified 50 variations in haplotype frequency distribution in the total group with hysteromyoma by HLA A-Cw subtype. The highest frequencies of haplotypes were identified for B17-Cw5 (3.9%), B7-Cw2, B8-Sw3 and B13-Cw3 (2.8% respectively). The lowest frequency encountered in nine haplotypes with a 1.1% rate. TABLE 3. SIGNIFICANT HAPLOTYPE ASSOCIATION IN THE TOTAL HYSTEROMYOMA GROUP Haplotypes D H Difference χ² LD - RR Р subtype В-C В5-Cw <0.001 В17-Cw <0.05 Note: D - expected frequency; H - observed frequency; LD - delta value of linkage disequilibrium; RRcriterion of the relative risk (relative risk); χ ² - Pearson's chi-square test. In this group there were identified two haplotypes having statistical significance in comparison to the control group (Table 3). The reliability in this group in comparison to the healthy one has been fixed for haplotypes: В17-Cw5 (χ²=5.13; RR= 12.3; LD=0.0025; Р<0.05) and В5-Cw4 (χ²=3.32; RR= 0.2; LD=0.0118; Р<0.001). Observed frequencies of haplotypes are 1.5 and 2.5 times higher than the theoretically expected values. But the true association was determined for B5-Cw4 haplotype in the hysteromyoma group. Conclusion Our studies in the total group of patients with hysteromyoma have established a positive association in the risk of hysteromyoma with HLA-B8 antigens, B22 and A28-B22 haplotype; antigens HLA-A28 Cw5 and B17-Sw5 haplotype perform as auxiliary markers. HLA-A2, B35, Cw4 antigens and A2-B35, B5-Cw4 haplotypes show the negative association. Studies of Ravshanov et al. (2000), Kuryazov et al. (2007), Kholikov et al. (2009) show that some antigenic variations (A2, A28, B35, Cw4 antigens) occur in these diseases represented by the group of indigenous women in Tashkent. Immunogenetic studies could be useful for searching of individual genes involved in determination of disease, particularly among patients with hysteromyoma. References Bland, M., et. al., An introduction to medical statistics, 3rd ed., Oxford University Press Müller, C., Ehninger, G., Goldmann S., 2003 Gene and haplotype frequency for the loci HLA-A, HLA-B, and HLA-DR based on over 13,000 German blood donors, Human Immunology, Vol.64, No.1, pp Egorova, V., Bermisheva, A., Khusnutdinova, K. et al., Current concepts of molecular and genetic basis of hysteromyoma [Zh. med. Genetics.], in Russian, Moscow, No.9, pp Howell, C. et al., Statistical methods for physiology 2nd Ed. PWS-Kent publishing company, pp Karell, K., Klinger, N., Holopainen, P. et al Major histocompatibility complex (MHC)-linked micro satellite markers in a founder population Tissue Antigens. Vol.56, pp
5 Kazubskaya, P., Bellevue, F., Nefedov, D., Other clinical and genetic analysis of primary multiple malignant neoplasms [Ros. oncology. Journ], in Russian, Moscow. No.2, pp.4-9 Khaitov, M., Alekseev, P., 2001., The physiological role of major histocompatibility complex of man, Zh. Immunology, No3, pp.4-11 Kholikov, K., Ghafoor-Akhundov, A., Aripova, W. et al., Immunogenetic approaches to the diagnosis of skin cancer in the Uzbek population. Nauch., Thm., Journ., Immunology. [them. II Mechnikov], in Russian, Moscow, Vol.30, No.5, pp Kuryazov, B., Aripova, T., Mirkamalova, L., Cancer of gastrointestinal tract [Rak jeludochnogo trakta], in Russian, Tashkent Lanchinsky, I., Ishchenko, I., Illarioshkin, N., Genetics and molecular biology of hysteromyoma / obstetrician and Gynecology, [Genetika i molekuljarnaya biologiya, mioma matki / akusherstvoginekologii], in Russian, Moscow., No.2, pp Mattius, L., Ihde, D., Piazza, A., Cepellini, R., Bodmer, F. et al., 1970 New approaches to the population genetic segregation analysis of the HLA system. In Terasaki PI (ed): Histocompatibility Testing. Copenhagen: Munksgaard Ravshanov, S., Tukhvatulin, Z., Muratova, T. et al., About the possibilities of using immunogenetic and cytogenetic methods for identifying genetic markers in Uzbek people having neoplasms, Collection of conference papers, 3rd All-Russian Scientific and Practical. Comference [ Sbornik dokladov, Vserossiyskaya nauchno-prakticheskaya Konferencia], in Russian, Moscow, January 25-27, pp Volkov, R., Evtushenko, I., Ivanov, S. et al., Myoma: Current state of matter, Siberian Journal of Medicine [Sibirskiy Med. Jurnal], in Russian, No.4, pp
Indian Journal of Nephrology Indian J Nephrol 2001;11: 88-97
88 Indian Journal of Nephrology Indian J Nephrol 2001;11: 88-97 ARTICLE HLA gene and haplotype frequency in renal transplant recipients and donors of Uttar Pradesh (North India) S Agrawal, AK Singh, RK
More informationHUMAN LEUCOCYTE ANTIGEN (HLA) CLASS I AND II FREQUENCIES IN SELECTED GROUPS IN LEBANON
Journal Scientifique Libanais, Vol. 1, No. 1, 2000 119 HUMAN LEUCOCYTE ANTIGEN (HLA) CLASS I AND II FREQUENCIES IN SELECTED GROUPS IN LEBANON Alexander M. Abdelnoor, May Abdelnoor, Walid Heneine, Firas
More informationSignificance of the MHC
CHAPTER 7 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ
More informationXIV. HLA AND TRANSPLANTATION MEDICINE
XIV. HLA AND TRANSPLANTATION MEDICINE A. Introduction 1. The HLA system includes a complex array of genes and their molecular products that are involved in immune regulation and cellular differentiation.
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationCellular Pathology of immunological disorders
Cellular Pathology of immunological disorders SCBM344 Cellular and Molecular Pathology Witchuda Payuhakrit, Ph.D (Pathobiology) witchuda.pay@mahidol.ac.th Objectives Describe the etiology of immunological
More informationTHE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES
THE MODERN GYNECOLOGIC EXAMINATION & SCREENING FOR GYNECOLOGIC MALIGNANCIES Denise Uyar, MD Associate Professor OB/GYN Chief Gynecologic Oncology Medical College of Wisconsin April 12, 2019 NO DISCLOSURES
More informationDOES THE BRCAX GENE EXIST? FUTURE OUTLOOK
CHAPTER 6 DOES THE BRCAX GENE EXIST? FUTURE OUTLOOK Genetic research aimed at the identification of new breast cancer susceptibility genes is at an interesting crossroad. On the one hand, the existence
More informationHLA and disease association
J Headache Pain (2000) 1:S109 S113 Springer-Verlag 2000 Simonetta Trabace HLA and disease association S. Trabace ( ) Section of Medical Genetics, Department of Experimental Medicine and Pathology, Department
More informationProfiling HLA motifs by large scale peptide sequencing Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009
Profiling HLA motifs by large scale peptide sequencing 2009 Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009 HLA Background The human leukocyte antigen system (HLA) is the
More information25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex
Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD
More informationDistribution of HLA Antigens Class I and II in Iraqi Arab population
Distribution of HLA s Class I and II in Iraqi Arab population *Ahmed A.A. Al-Hassan, MSc, Immunology ; **Sana a Al-Naseri, MD, ph.d, immunopathology *** Batool H. Al-Ghurabi, ph.d, Immunology **** Mohammed
More informationTumori eredofamiliari: sorveglianza di donne ad alto rischio
Tumori eredofamiliari: sorveglianza di donne ad alto rischio 14/01/2018 Dott Matteo Generali AUSL Modena Carpi U.O. Ostetricia e Ginecologia Screening for gynaecologic cancer in genetically predisposed
More informationThe Major Histocompatibility Complex
The Major Histocompatibility Complex Today we will discuss the MHC The study of MHC is necessary to understand how an immune response is generated. And these are the extra notes with respect to slides
More informationAntigen Presentation to T lymphocytes
Antigen Presentation to T lymphocytes Immunology 441 Lectures 6 & 7 Chapter 6 October 10 & 12, 2016 Jessica Hamerman jhamerman@benaroyaresearch.org Office hours by arrangement Antigen processing: How are
More informationCancer Genomics 101. BCCCP 2015 Annual Meeting
Cancer Genomics 101 BCCCP 2015 Annual Meeting Objectives Identify red flags in a person s personal and family medical history that indicate a potential inherited susceptibility to cancer Develop a systematic
More informationthe HLA complex Hanna Mustaniemi,
the HLA complex Hanna Mustaniemi, 28.11.2007 The Major Histocompatibility Complex Major histocompatibility complex (MHC) is a gene region found in nearly all vertebrates encodes proteins with important
More informationHLA and more. Ilias I.N. Doxiadis. Geneva 03/04/2012.
www.ebmt.org HLA and more Ilias I.N. Doxiadis Geneva 03/04/2012 HLA and more HLA and more / Doxiadis 2 Topic of the day Compatibility testing is a type of testing used to ensure compatibility of the system/application/website
More informationHistorical definition of Antigen. An antigen is a foreign substance that elicits the production of antibodies that specifically binds to the antigen.
Historical definition of Antigen An antigen is a foreign substance that elicits the production of antibodies that specifically binds to the antigen. Historical definition of Antigen An antigen is a foreign
More informationSignificance of the MHC
CHAPTER 8 Major Histocompatibility Complex (MHC) What is is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) Significance of the MHC role in immune response role in organ
More informationThe MHC and Transplantation Brendan Clark. Transplant Immunology, St James s University Hospital, Leeds, UK
The MHC and Transplantation Brendan Clark Transplant Immunology, St James s University Hospital, Leeds, UK Blood Groups Immunofluorescent staining has revealed blood group substance in the cell membranes
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): October 1, 2014 Most Recent Review Date (Revised): May 20, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Hosted by: Australian Small Animal Veterinary Association (ASAVA) Australian Small Animal Veterinary Association (ASAVA)
More informationDocumentation of Changes to EFI Standards: v 5.6.1
Modified Standard B - PERSONNEL QUALIFICATIONS B1.000 The laboratory must employ one or more individuals who meet the qualifications and fulfil the responsibilities of the Director/Co-Director, Technical
More informationChapter 10. Histocompatibility Testing
Chapter 10 Histocompatibility Testing Chapter 10 Histocompatibility Testing Table of Contents 10.1 General... 3 10.1.1 Registration of renal transplant patients...3 10.1.2 Material for histocompatibility
More informationG-CSF-primed autologous and allogeneic bone marrow for transplantation in clinical oncology. Cell content and immunological characteristics
Journal of Physics: Conference Series PAPER OPEN ACCESS G-CSF-primed autologous and allogeneic bone marrow for transplantation in clinical oncology. Cell content and immunological characteristics To cite
More informationHLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol
HLA and antigen presentation Department of Immunology Charles University, 2nd Medical School University Hospital Motol MHC in adaptive immunity Characteristics Specificity Innate For structures shared
More informationDr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION
Benjamini. Ch. 19, Pgs 379-399 Page 1 of 10 TRANSPLANTATION I. KINDS OF GRAFTS II. RELATIONSHIPS BETWEEN DONOR AND RECIPIENT Benjamini. Ch. 19, Pgs 379-399 Page 2 of 10 II.GRAFT REJECTION IS IMMUNOLOGIC
More informationMinimal Requirements for Histocompatibility & Immunogenetics Laboratory
Minimal Requirements for Histocompatibility & Immunogenetics Laboratory The 4 th WBMT Congress and Workshop Riyadh, KSA - January 15-17, 2017 HLA Discovery, 1958 The Nobel Prize in Physiology or Medicine
More information6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017
Genetics 101 Hereditary Breast and Ovarian Cancer 2017 Rebecca Sutphen, MD, FACMG Professor, College of Medicine President & Chief Medical Officer INVASIVE CANCER GENETICALLY ALTERED CELL HYPERPLASIA DYSPLASIA
More informationTUMOR M ARKERS MARKERS
TUMOR MARKERS M.Shekarabi IUMS Definition Many cancers are associated with the abnormal production of some molecules l which h can be measured in plasma. These molecules are known as tumor markers. A good
More informationClinical Relevance of the HLA System in Blood Transfusion. Dr Colin J Brown PhD FRCPath. October 2017
Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD
More informationRole of NMDP Repository in the Evolution of HLA Matching and Typing for Unrelated Donor HCT
Role of NMDP Repository in the Evolution of HLA Matching and Typing for Unrelated Donor HCT Stephen Spellman, MBS Director, Immunobiology and Observational Research Assistant Scientific Director CIBMTR,
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationChapter 10. Histocompatibility Testing
Chapter 10 Histocompatibility Testing Change record Date Author Version Change reference 08-03-2013 J. de Boer 2.0 Textual Adjustments 13-09-2012 C.M. Tieken 1.1 Text added page 2 10-03-2012 I. Doxiadis
More informationIMMUNOGENETICS AND TRANSPLANTATION
IMMUNOGENETICS AND TRANSPLANTATION WHAT S THE MHC GOT TO DO WITH TRANSPLANTATION? We have learned that the molecules of Class I and II MHC are involved in presenting antigenic peptides to the receptors
More informationThe major histocompatibility complex (MHC) is a group of genes that governs tumor and tissue transplantation between individuals of a species.
Immunology Dr. John J. Haddad Chapter 7 Major Histocompatibility Complex The major histocompatibility complex (MHC) is a group of genes that governs tumor and tissue transplantation between individuals
More informationHistocompatibility antigens
Histocompatibility antigens Tuesday 09 November 2010 Telegraph UK Livers grown in the laboratory could eventually solve organ transplant shortage. Made-to-measure organs for transplantation are a step
More informationHLA AND DISEASE. M. Toungouz Nevessignsky. Erasme Hospital Brussels, Belgium EFI - ULM 2009
HLA AND DISEASE M. Toungouz Nevessignsky Université Libre de Bruxelles (ULB) Erasme Hospital Brussels, Belgium HLA and disease: pioneer studies 1972: Falcuk et al HLA B8 and coeliac disease 1972: Russell
More informationEDUCATIONAL COMMENTARY CA 125. Learning Outcomes
EDUCATIONAL COMMENTARY CA 125 Learning Outcomes Upon completion of this exercise, participants will be able to: discuss the use of CA 125 levels in monitoring patients undergoing treatment for ovarian
More informationClonal evolution of human cancers
Clonal evolution of human cancers -Pathology-based microdissection and genetic analysis precisely demonstrates molecular evolution of neoplastic clones- Hiroaki Fujii, MD Ageo Medical Laboratories, Yashio
More informationMendel s Methods: Monohybrid Cross
Mendel s Methods: Monohybrid Cross Mendel investigated whether the white-flowered form disappeared entirely by breeding the F1 purple flowers with each other. Crossing two purple F1 monohybrid plants is
More informationSignificance of the MHC
CHAPTER 8 Major Histocompatibility Complex (MHC) What is MHC? HLA H-2 Minor histocompatibility antigens Peter Gorer & George Sneell (1940) - MHC molecules were initially discovered during studies aimed
More information11-1: Introduction to Genetics
11-1: Introduction to Genetics The Work of Gregor Mendel Copyright Pearson Prentice Hall Genetics Vocabulary Genetics The study of heredity. Heredity The passing of physical characteristics from parents
More informationConditions. Name : dummy Age/sex : xx Y /x. Lab No : xxxxxxxxx. Rep Centre : xxxxxxxxxxx Ref by : Dr. xxxxxxxxxx
Name : dummy Age/sex : xx Y /x Lab No : xxxxxxxxx Rep Centre : xxxxxxxxxxx Ref by : Dr. xxxxxxxxxx Rec. Date : xx/xx/xx Rep Date : xx/xx/xx GENETIC MAPPING FOR ONCOLOGY Conditions Melanoma Prostate Cancer
More informationA Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube
A Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube Kate Madhuri S 1, Gulhane Sushma R 2, Mane Sheetal V 3 1 Professor and Head, 2 Specialist cum
More informationGenetics After Mendel
Genetics After Mendel Genetics After Mendel Single factor inheritance Mendel found traits as dominant or recessive Some instances where the former rule does not apply: Incomplete Dominance Co-dominance
More informationBasel - 6 September J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva
Basel - 6 eptember 2012 J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva Outline the HLA system is (a) complex anti-hla immunisation and alloreactivity
More informationHLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma Arezou Sayad 1, Mohammad Taghi Akbari 2**, Mahshid Mehdizadeh 3,4, Mohammad Taheri 1, Abbas Hajifathali 3* 1 Department of Medical
More informationGenetic testing for hereditary cancer. An overview for healthcare providers
Genetic testing for hereditary cancer An overview for healthcare providers Specimen requirements Whole blood Two 4.5 ml EDTA tubes (lavender top) Please wait at least 2 weeks after a packed cell/platelet
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationimproved with an MIS approach. This clinical benefit for American women has been demonstrated with Level I evidence. Hysterectomy is one of the most
Statement of the Society of Gynecologic Oncology to the Food and Drug Administration s Obstetrics and Gynecology Medical Devices Advisory Committee Concerning Safety of Laparoscopic Power Morcellation
More informationT-cell receptor feature. Antibody/antigen interaction. Major Histocompatibility Complex. Antigen processing. Antigen presentation
ntibody/antigen interaction Major Histocompatibility Complex ntigen processing ntigen presentation PC/T-cell interaction T-cell receptor feature CD4+ T-Cell HL/peptide/TCR complex CD8+ T-Cell Proteasome
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Evaluation of Thyroid Profile in Patients with Abnormal Uterine Bleeding Rema. V. Nair 1*,
More informationTransplantation. Immunology Unit College of Medicine King Saud University
Transplantation Immunology Unit College of Medicine King Saud University Objectives To understand the diversity among human leukocyte antigens (HLA) or major histocompatibility complex (MHC) To know the
More informationAutoimmune diseases. Autoimmune diseases. Autoantibodies. Autoimmune diseases relatively common
Autoimmune diseases Fundamental abnormality: the adaptive immune system is triggered by self antigens to initiate a sustained immune response against self molecules that results in tissue injury Specificity
More informationGenotyping of HLA-class-I by PCR-SSP of Iraqi Breast Cancer Patients
Genotyping of HLA-class-I by PCR-SSP of Iraqi Breast Cancer Patients Ahmed A.Al-Hassan 1 PhD, Nidhal Abdul Muhymen 1 MSc;PhD,Ala'a Ghany Hussien 2 FICMS, Ameera J. Al-Nema 3 MBChB. Abstract Background:
More informationGYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer
GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer Causes of Hereditary Ovarian and Uterine Cancer uterine cancer ovarian cancer Sporadic 75-90% Sporadic 70-80% Hereditary, 5% Lynch syndrome
More informationAtlas Of Gynecologic Surgical
Atlas Of Gynecologic Surgical 1 / 6 2 / 6 3 / 6 Atlas Of Gynecologic Surgical This atlas of surgical videos is enhanced with medically accurate 3D animation and aims to instruct surgeons in the surgical
More informationGynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationGynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationWHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.
WHAT IS A GENE? CHROMOSOME E GEN DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE
More informationGYNplus. genetic testing for hereditary ovarian and/or uterine cancer
GYNplus genetic testing for hereditary ovarian and/or uterine cancer What Are the Causes of Hereditary Ovarian and Uterine Cancer? uterine cancer ovarian cancer sporadic 70-80% hereditary 5% Lynch syndrome
More informationMedical Genetics in Undergraduate Medicine
Medical Genetics in Undergraduate Medicine Sandra Marles Section Leader without Separate Clerkship Overall Goal of New Genetics Curriculum To integrate teaching of genetic principles, genetic diseases
More informationThe Use of HLA /HPA Selected Platelets
The Use of HLA /HPA Selected Platelets Dr Colin Brown PhD FRCPath. Consultant Clinical Scientist Histocompatibility and Immunogenetics HLA and Transfusion Human Leucocyte Antigens HLA Human Platelet Antigens
More informationMerck Oncology Overview. The Development of MSI-H Cancer Therapy. Development of Anti-Cancer Drugs Forum Tokyo, Japan, 18, February 2017
Merck Oncology Overview The Development of MSI-H Cancer Therapy Development of Anti-Cancer Drugs Forum Tokyo, Japan, 18, February 217 Andrew Joe, MD Executive Director, Late Stage Oncology Merck & Co.,
More informationHow to Find an Unrelated Donor Theory & Technology
How to Find an Unrelated Donor Theory & Technology Carlheinz R. Müller Zentrales Knochenmarkspender-Register für die Bundesrepublik Deutschland (ZKRD) Ulm, Germany How to Find an Unrelated Donor HLA-Basics
More informationThe Major Histocompatibility Complex of Genes
The Major Histocompatibility Complex of Genes Topic 4 The Major Histocompatibility Complex Outline of Lectures The immunological reasons for transplant rejection How the MHC was discovered using inbred
More informationBLOOD GROUPS DISTRIBUTION PATTERN AMONG LIMITED ADULT HUMAN POPULATION OF DISTRICT GILGIT, GILGIT-BALTISTAN, PAKISTAN
International Journal of Pure and Applied Zoology Volume 6, Issue 2, pp: 18-24, 2018 http://www.ijpaz.com Research Article ISSN (Print) : 2320-9577 ISSN (Online): 2320-9585 BLOOD GROUPS DISTRIBUTION PATTERN
More informationCHAPTER 18: Immune System
CHAPTER 18: Immune System 1. What are four characteristics of the specific immune system? a. b. c. d. 2. List the two main types of defense mechanisms and briefly describe features of each. 3. Give examples
More informationCS2220 Introduction to Computational Biology
CS2220 Introduction to Computational Biology WEEK 8: GENOME-WIDE ASSOCIATION STUDIES (GWAS) 1 Dr. Mengling FENG Institute for Infocomm Research Massachusetts Institute of Technology mfeng@mit.edu PLANS
More informationIMMUNOGENETICS AND INTRODUCTION TO TRANSPLANTATION
IMMUNOGENETICS AND INTRODUCTION TO TRANSPLANTATION WHAT S THE MHC GOT TO DO WITH TRANSPLANTATION? We have learned that Class I and II MHC are involved in presenting antigenic peptides to the receptors
More informationMULTIFACTORIAL DISEASES. MG L-10 July 7 th 2014
MULTIFACTORIAL DISEASES MG L-10 July 7 th 2014 Genetic Diseases Unifactorial Chromosomal Multifactorial AD Numerical AR Structural X-linked Microdeletions Mitochondrial Spectrum of Alterations in DNA Sequence
More informationFemale Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan
Female Genital Tract Lab Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan Ovarian Pathology A 20-year-old female presented with vague left pelvic pain. Pelvic exam revealed
More informationPMS2 gene. Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) PMS2 Summary Cancer Risk Table
PMS2 gene Associated Syndrome Name: Lynch syndrome/hereditary NonPolyposis Colorectal Cancer (HNPCC) PMS2 Summary Cancer Risk Table CANCER Colorectal GENETIC CANCER RISK High Risk Endometrial High Risk
More informationGEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics
GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics The Medical/Surgical/Radiation Oncologist s View of Genetics Cancer
More informationGenetic Risk Assessment for Cancer
Genetic Risk Assessment for Cancer Jennifer Siettmann, MS CGC Certified Genetic Counselor/Cancer Risk Counselor Banner Good Samaritan Cancer Screening & Prevention Program Objectives Describe the role
More informationImmunology Lecture 4. Clinical Relevance of the Immune System
Immunology Lecture 4 The Well Patient: How innate and adaptive immune responses maintain health - 13, pg 169-181, 191-195. Immune Deficiency - 15 Autoimmunity - 16 Transplantation - 17, pg 260-270 Tumor
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/20898 holds various files of this Leiden University dissertation. Author: Jöris, Monique Maria Title: Challenges in unrelated hematopoietic stem cell transplantation.
More informationFacing Gynecologic Surgery?
Facing Gynecologic Surgery? Domenico Vitobello, MD Domenico Vitobello is the medical director of the Gynecologic Unit at the Humanitas Clinical and Research Center since 2009. He has developed a comprehensive
More informationGenetics and Genomics in Medicine Chapter 8 Questions
Genetics and Genomics in Medicine Chapter 8 Questions Linkage Analysis Question Question 8.1 Affected members of the pedigree above have an autosomal dominant disorder, and cytogenetic analyses using conventional
More informationHLA-A, B, DR, and DQ Antigens in Indian Patients with Severe Chronic Rheumatic Heart Disease
HLA-A, B, DR, and DQ Antigens in Indian Patients with Severe Chronic Rheumatic Heart Disease Breminand MAHARAJ, MD, Shaun M. KHEDUN, M Med Sci, Michael G. HAMMOND, DSc, and Kenneth van der Byl, BSc R SUMMARY
More informationreproductive organs. Malignant neoplasms. 4. Inflammatory disorders of female reproductive organs 2 5. Infertility. Family planning.
Thematic plan of lectures module iii. Diseases of female reproductive system. Family planning. Topic No of hours 1. Disturbances of menstrual function. Neuroendocrinological 2 syndromes in gynecology 1.
More informationInfertility testing. Global infertility panel. Patient information. Informations for patients
Global infertility panel Infertility testing Informations for patients Patient information Each of your body cells contains your genetic information called DNA. DNA carries all the information you need
More informationIn this Nobel Prize winning paper the authors found chemotherapy and radiation poor methods of Cancer treatment
In this Nobel Prize winning paper the authors found chemotherapy and radiation poor methods of Cancer treatment The Nobel Prize in Physiology or Medicine 1980 Presentation Speech Presentation Speech by
More informationGENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER BRCA1 BRCA2
GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER BRCA1 BRCA2 Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationHLA ANTIGEN FREQUENCY OF NORTHERN IRELAND BLOOD DONORS
HLA ANTIGEN FREQUENCY OF NORTHERN IRELAND BLOOD DONORS by D. MIDDLETON Transplantation and Clinical Immunology, Belfast City Hospital J. MARTIN * Transplantation and Clinical Immunology, Belfast City Hospital
More informationA Rare Uterine Mass-case Report
Indian Journal of Science and Technology A Rare Uterine Mass-case Report N. Hephzibah Kirubamani 1* and Shruthi Kamal 2 1 Professor, Obstetrics & Gyneacology, Saveetha Medical college- Saveetha University,
More informationDetermination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study
Tissue Antigens ISSN 0001-2815 Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study N. Ikeda 1,H.Kojima 1,M.Nishikawa 1, K. Hayashi 1, T. Futagami
More informationImmunotherapy on the Horizon: Adoptive Cell Therapy
Immunotherapy on the Horizon: Adoptive Cell Therapy Joseph I. Clark, MD, FACP Professor of Medicine Loyola University Chicago Stritch School of Medicine Maywood, IL June 23, 2016 Conflicts of Interest
More informationTransplantation Immunology Booklet C
Booklet C Pretest Correct Answers 3. (C) is correct. One of the major barriers to successful hematopoietic stem cell transplantation is the antigens coded for by the major histocompatibility gene complex.
More informationGenetics: CH9 Patterns of Inheritance
Genetics: CH9 Patterns of Inheritance o o Lecture note Directions Highlight Key information (10-30% of most slides) My Thoughts: Questions, comments, additional information, connections to prior knowledge,
More informationDefinition of MHC supertypes through clustering of MHC peptide binding repertoires
Definition of MHC supertypes through clustering of MHC peptide binding repertoires Pedro A. Reche and Ellis L. Reinherz Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer
More informationCompleting the CIBMTR Confirmation of HLA Typing Form (Form 2005)
Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005) Stephen Spellman Research Manager NMDP Scientific Services Maria Brown Scientific Services Specialist Data Management Conference 2007 1
More informationOncology Drug Development Using Molecular Pathology
Oncology Drug Development Using Molecular Pathology Introduction PRESENTERS Lee Schacter, PhD, MD, FACP Executive Medical Director, Oncology Clinipace Worldwide Martha Bonino Director, Strategic Accounts
More informationGenetics of B27-associated diseases 1
Ann. rheum. Dis. (1979), 38, Supplement p. 135 Genetics of B27-associated diseases 1 J. C. WOODROW From the Department of Medicine, University of Liverpool, Liverpool The genetic analysis of those conditions
More informationGo to slide 11
11-29-17 Go to slide 11 Blood Typing & Spatter Come in and get your notebooks out. We have notes today! Forensic serology is the detection, classification and study of various bodily fluids such as blood,
More information